Patent details

Basic Information

Publication number:

LUC00264

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP087583597

Legal Status:

Inactive

Application number:

LUC00264

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/21/1596

Marketing Authorization Type:

Marketing Authorization Date:

17/02/2022

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

25/05/2022

First Marketing Authorization date:

17/02/2022

Grant date:

25/04/2025

Activation date:

Publication date:

25/05/2022

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

29/04/2033

SPC Extension Expiration:

29/04/2033

Rejection date:

Withdrawal date:

Owner

From:

25/05/2022

 

 

Name:

Merck Patent GmbH

Address:

Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

25/05/2022

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2022/07

Publication date:

03/06/2022

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2025/06

Publication date:

12/05/2025

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

01/05/2028

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
25/05/2022	MA publication	10
25/05/2022	Application Form	3
25/05/2022	Marketing authorization	3
25/05/2022	Summary of the product caracteristics	30
25/05/2022	Outgoing Correspondence	1
25/05/2022	Publication	1
25/04/2025	Publication	1
25/04/2025	Certificate	1
25/04/2025	Outgoing Correspondence	1